RAD51 and cancer: A poor sensitivity of Western blot has been pointed out by Carlomagno et al (2000), who demonstrated that the expression levels of nine different proteins, and among them Rad51, in 10 cell lines obtained from the skin biopsies of cancer patients with different clinical radiosensitivities were similar to those in three control cell lines.